Just a few short hours ago we were treated to a plethora of talking-heads proclaiming "see, this is it... the dip to be bought." But now, led by Biotechs as well as more 'growth' weakness, the Nasdaq has piled back below the critical 4000 level and broken to new cycle lows... we anxiously await the 330 Ramp to see just how much damage they can do (though stocks did catch perfectly down to USDJPY's early weakness)
New cycle lows for the Nasdaq
[3]
and violent catch-down for the S&P...
[4]